Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...

Milestone Payment Triggered by Initiation of Additional Preclinical Studies for REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia –– Extends Cash Runway through 2027 –NEW ...

Rallybio (RLYB) announced that it received an equity milestone payment of $12.5M from Recursion Pharmaceuticals (RXRX). The milestone payment was ...

The most profound failures in history are not those that bet big and lost, but those that failed to bet at all. Incremental advances will never cure Alzheimer’s disease or reverse climate change. To ...

Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.

Venice: After a fourteen-year absence, McElwee returns to filmmaking with an affecting tribute to his son’s life that doubles ...

Recursion, Exscientia, and AI drug discovery’s moment of truth Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.

Central bank buying can continue to hold the floor for gold, but a re-ignition of ETF inflows is needed for prices to break out higher once again.” – Natasha Kaneva, head of global commodities ...

Investor Martin Casado watched software disrupt industries for decades. Now, he says it's "fun to actually be the disrupted ...

Repetition is important for learning, helping us to gain new information and skills. Unfortunately, advertisers, politicians, ...

With vibe-coding, anyone can become a coder. But can they grow into a software engineer?

Thanks to AI, we’re entering a new era where software completes tasks independently, taking software far beyond being a tool ...